The Global Head And Neck Cancer Therapeutics Market is Predict to reach $2.5 Billion by 2028, at a CAGR of 12.3%

Published Date: 30-Nov-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Head And Neck Cancer Therapeutics Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Head And Neck Cancer Therapeutics Market size is expected to reach $2.5 billion by 2028, rising at a market growth of 12.3% CAGR during the forecast period.

The Targeted Therapy segment is showcasing a CAGR of 12.6% during (2022 - 2028). It is because targeted therapy refers to a treatment that targets the specific genes, proteins, or tissue environment that promotes the growth and survival of cancer. This method of therapy inhibits the development and proliferation of cancer cells while minimizing harm to healthy cells. The targeted treatment has shown promising and beneficial outcomes as a therapeutic option for individuals with head and neck cancer.

The Injectable segment acquired maximum revenue share in the Global Head & Neck Cancer Therapeutics Market by Route of Administration in 2021 thereby, achieving a market value of $2.1 billion by 2028. It is because the new treatments for cancer of the head and neck involve direct injection of the therapeutic substance into the malignant lesions. This locoregional treatment permits the adaption of traditional chemotherapy drugs, to reach larger drug concentrations in the tumor while avoiding significant systemic toxicity.

The Hospital Pharmacies segment has shown the growth rate of 12.7% during (2022 - 2028). In every hospital ward, pharmacists provide a medication reconciliation program for inpatients to improve the quality of therapy and reduce the workload of physicians and nurses. The pharmacist collects, compiles, and maintains a database of medication information and distributes relevant data to the medical personnel. Through paper distribution and/or the in-hospital computer network, drug information is rapidly communicated across the hospital.

The North America market dominated the Global Head & Neck Cancer Therapeutics Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1 billion by 2028. The Europe market is exhibiting a CAGR of 11.6% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 13.4% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/head-and-neck-cancer-therapeutics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca Plc, Bristol Myers Squibb Company, and Clinigen Group PLC.

Global Head And Neck Cancer Therapeutics Market Segmentation

By Therapy Type

  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy

By Route of Administration

  • Injectable
  • Oral

By Distribution Channel

  • Retail & Specialty Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceuticals Industries Ltd.
  • F. Hoffmann-La Roche Ltd.
  • AstraZeneca Plc
  • Bristol Myers Squibb Company
  • Clinigen Group PLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Head And Neck Cancer Therapeutics Market Future Scope & Opportunities 2022-2028

Europe Head And Neck Cancer Therapeutics Market Size & Growth Forecast 2022-2028

Asia Pacific Head And Neck Cancer Therapeutics Market Size, Share & Industry Outlook to 2028

LAMEA Head And Neck Cancer Therapeutics Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.